This inventor holds 1 USPTO granted patent. Top assignee: Pharmadax Inc.. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Chieh-Wen Chang: Innovator in Pharmaceutical Formulations
Introduction
Chieh-Wen Chang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative work focuses on improving drug delivery systems to enhance patient compliance and therapeutic outcomes.
Latest Patents
Chieh-Wen Chang holds a patent for a "Sustained release oral dosage form containing dalfampridine." This invention provides a sustained release oral dosage form that can be administered once daily. The formulation includes dalfampridine as the active pharmaceutical ingredient, along with excipients comprising osmotic agents in a tablet core. This innovative dosage form is designed to minimize adverse effects, prevent alcohol-induced dose dumping, and maintain a consistent drug plasma concentration.
Career Highlights
Chieh-Wen Chang is currently associated with Pharmadax Inc., where he continues to work on advancing pharmaceutical formulations. His expertise in drug delivery systems has positioned him as a valuable asset in the industry. With a focus on patient-centered solutions, he aims to improve the efficacy and safety of medications.
Collaborations
Chieh-Wen Chang collaborates with talented professionals in his field, including Chih-Yao Yang and Jen-Sen Wu. These collaborations foster innovation and enhance the development of new pharmaceutical products.
Conclusion
Chieh-Wen Chang's contributions to the pharmaceutical industry, particularly through his patent on sustained release oral dosage forms, highlight his commitment to improving patient care. His work exemplifies the importance of innovation in drug delivery systems.